These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2113555)

  • 1. Multiple calcium-mediated mechanisms regulate c-myc expression in HL-60 cells.
    Salehi Z; Niedel JE
    J Immunol; 1990 Jul; 145(1):276-82. PubMed ID: 2113555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex regulation of macrophage colony-stimulating factor in the HL-60 promyelocytic cell line.
    Sater RA; Cripe LD; Taylor JD; Niedel JE
    J Immunol; 1991 Jul; 147(2):633-7. PubMed ID: 2071899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of retinoic acid and calcium ionophore A23187 on differentiation, c-myc expression, and membrane tyrosine kinase activity in human promyelocytic leukemia cell line HL-60.
    Chapekar MS; Hartman KD; Knode MC; Glazer RI
    Mol Pharmacol; 1987 Feb; 31(2):140-5. PubMed ID: 3100942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of phorbol ester-induced down-regulation of myc protein in the phorbol ester-tolerant mutant of HL-60 promyelocytes.
    Gailani D; Cadwell FJ; O'Donnell PS; Hromas RA; Macfarlane DE
    Cancer Res; 1989 Oct; 49(19):5329-33. PubMed ID: 2670202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of phorbol myristate acetate on c-myc, beta-actin, and FV gene expression in morphologically recognizable human megakaryocytes: a kinetic analysis employing in situ hybridization.
    Gewirtz AM; Shen YM
    Exp Hematol; 1990 Sep; 18(8):945-52. PubMed ID: 2201557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional down-regulation of c-myc expression by protein synthesis-dependent and -independent pathways in a human T lymphoblastic tumor cell line.
    Bading H; Moelling K
    Cell Growth Differ; 1990 Mar; 1(3):113-7. PubMed ID: 2127692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirements for the simultaneous presence of phorbol esters and calcium ionophores in the expression of human T lymphocyte proliferation-related genes.
    Kumagai N; Benedict SH; Mills GB; Gelfand EW
    J Immunol; 1987 Sep; 139(5):1393-9. PubMed ID: 3114365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two different molecular pathways account for low IL-2 receptor and c-myc mRNA expression by lpr Lyt-2- L3T4- T cells.
    Katagiri K; Katagiri T; Yokota S; Eisenberg RA; Cohen PL; Ting JP
    J Immunol; 1988 Sep; 141(6):2145-52. PubMed ID: 3139753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of cellular oncogene expression in mouse lymphocytes. II. Regulation of c-fos and c-myc gene expression.
    Schneider-Schaulies J; Schimpl A; Wecker E
    Eur J Immunol; 1987 May; 17(5):713-8. PubMed ID: 3556196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
    St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
    Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional control of c-myc gene expression during stimulation of murine B lymphocytes.
    Buckler AJ; Rothstein TL; Sonenshein GE
    J Immunol; 1990 Jul; 145(2):732-6. PubMed ID: 2195118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of a constitutive transcriptional block at exon-1 controls human c-myc oncogene expression.
    Re GG; Antoun GR; Zipf TF
    Oncogene; 1990 Aug; 5(8):1247-50. PubMed ID: 1697411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
    Morello D; Lavenu A; Babinet C
    Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered regulation of c-myc in an HL-60 differentiation resistant subclone, HL-60-1E3.
    Ely CM; Leftwich JA; Chenevix-Trench G; Hall RE; Westin EH
    Cancer Res; 1987 Sep; 47(17):4595-600. PubMed ID: 3476196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncoupling of c-myc mRNA expression from G1 events in human T lymphocytes.
    Friedrich B; Gullberg M; Lundgren E
    Anticancer Res; 1988; 8(1):23-8. PubMed ID: 3128958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bombesin induction of c-fos and c-myc proto-oncogenes in Swiss 3T3 cells: significance for the mitogenic response.
    Rozengurt E; Sinnett-Smith JW
    J Cell Physiol; 1987 May; 131(2):218-25. PubMed ID: 3108267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of recombinant human transforming growth factor-beta 1 or/and interleukin-6 on growth inhibition and proto-oncogene c-myc expression in human leukemia cells.
    Feng R; Shen S; Hui H; Jin M
    Chin Med J (Engl); 1997 Nov; 110(11):847-50. PubMed ID: 9772416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific post-transcriptional regulation of c-myc expression in normal and H-2K/human c-myc transgenic mice.
    Morello D; Asselin C; Lavenu A; Marcu KB; Babinet C
    Oncogene; 1989 Aug; 4(8):955-61. PubMed ID: 2668846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-myc expression is down-regulated in mafosfamide-treated HL-60 cells undergoing apoptosis.
    Davidoff AN; Mendelow BV
    Anticancer Res; 1993; 13(4):1167-70. PubMed ID: 8352540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bryostatin induces changes in protein kinase C location and activity without altering c-myc gene expression in human promyelocytic leukemia cells (HL-60).
    Kraft AS; Baker VV; May WS
    Oncogene; 1987 May; 1(2):111-8. PubMed ID: 3325877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.